Drug · DIN 02449587
ESOMEPRAZOLE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since October 31, 2017.
- Drug Identification Number (DIN)
- 02449587
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Delayed-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Esomeprazole A02BC05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 17, 2015: NOC 17587New Drug Submission (NDS) · Licensing agreement between two companies
Other DINs named ESOMEPRAZOLE
- DIN 02394839 · Marketed
- DIN 02394847 · Marketed
- DIN 02442493 · Marketed
- DIN 02442507 · Marketed
- DIN 02520699 · Marketed
- DIN 02520702 · Marketed
- DIN 02417480 · Approved
- DIN 02417499 · Approved
- DIN 02431173 · Dormant
- DIN 02438461 · Cancelled Pre Market
- DIN 02438488 · Cancelled Pre Market
- DIN 02449595 · Cancelled Pre Market
- DIN 02535335 · Dormant